These findings suggest that mutations of these cancer-driver genes contribute to the development of cholesterol-associated NASH-HCC, and the authors suggest that Mtor and Sdk1 may also function as cancer drivers in NASH-HCC [100]. Here, SDK1 is linked to metabolic dysfunction-associated steatohepatitis.